OncoLens Raises $2.5 Million in Pre-Series A Funding

OncoLens, a pioneer in tumor board and cancer treatment planning software solutions, today announced it has raised a Pre-Series A funding of $2.5 million led by venture investment firm BIP Capital. Ot...

Read More +

OncoLens Adds Features to Help Cancer Centers Achieve NAPRC Accreditation

OncoLens, a pioneer in tumor board and cancer treatment planning software solutions, recently announced the availability of its new workflow, data collection, and reporting features that help cancer c...

Read More +

OncoLens Selected as a Venture Atlanta 2019 Presenting Company

OncoLens announced today that it has been chosen out of hundreds of applicants as one of the top 36 rising star technology companies in the Southeast that will present on stage at Venture Atlanta 2019...

Read More +